165 related articles for article (PubMed ID: 33249459)
1. Cerebrospinal Fluid Lactate as a Prognostic Marker of Disease Severity and Mortality in Cryptococcal Meningitis.
Abassi M; Bangdiwala AS; Nuwagira E; Kandole Tadeo K; Okirwoth M; Williams DA; Mpoza E; Tugume L; Ssebambulidde K; Huppler Hullsiek K; Musubire AK; Muzoora C; Rhein J; Meya DB; Boulware DR
Clin Infect Dis; 2021 Nov; 73(9):e3077-e3082. PubMed ID: 33249459
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and Prognostic Value of Cerebrospinal Fluid Lactate and Glucose in HIV-Associated Tuberculosis Meningitis.
Nuwagira E; Huppler Hullsiek K; Jjunju S; Rutakingirwa M; Kasibante J; Tadeo KK; Kagimu E; Tugume L; Ssebambulidde K; Musubire AK; Bangdiwala A; Muzoora C; Meya DB; Boulware DR; Bahr NC; Creswell FV
Microbiol Spectr; 2022 Aug; 10(4):e0161822. PubMed ID: 35727068
[TBL] [Abstract][Full Text] [Related]
3. Cryptococcus neoformans ex vivo capsule size is associated with intracranial pressure and host immune response in HIV-associated cryptococcal meningitis.
Robertson EJ; Najjuka G; Rolfes MA; Akampurira A; Jain N; Anantharanjit J; von Hohenberg M; Tassieri M; Carlsson A; Meya DB; Harrison TS; Fries BC; Boulware DR; Bicanic T
J Infect Dis; 2014 Jan; 209(1):74-82. PubMed ID: 23945372
[TBL] [Abstract][Full Text] [Related]
4. Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal Meningitis.
Kasibante J; Irfanullah E; Wele A; Okafor E; Ssebambulidde K; Okurut S; Kagimu E; Gakuru J; Rutakingirwa MK; Mugabi T; Nuwagira E; Jjunju S; Mpoza E; Tugume L; Nsangi L; Musibire AK; Muzoora C; Rhein J; Meya DB; Boulware DR; Abassi M
medRxiv; 2023 Dec; ():. PubMed ID: 38168371
[TBL] [Abstract][Full Text] [Related]
5. Relationship of cerebrospinal fluid pressure, fungal burden and outcome in patients with cryptococcal meningitis undergoing serial lumbar punctures.
Bicanic T; Brouwer AE; Meintjes G; Rebe K; Limmathurotsakul D; Chierakul W; Teparrakkul P; Loyse A; White NJ; Wood R; Jaffar S; Harrison T
AIDS; 2009 Mar; 23(6):701-6. PubMed ID: 19279443
[TBL] [Abstract][Full Text] [Related]
6. Symptomatic Cryptococcal Antigenemia Presenting as Early Cryptococcal Meningitis With Negative Cerebral Spinal Fluid Analysis.
Ssebambulidde K; Bangdiwala AS; Kwizera R; Kandole TK; Tugume L; Kiggundu R; Mpoza E; Nuwagira E; Williams DA; Lofgren SM; Abassi M; Musubire AK; Cresswell FV; Rhein J; Muzoora C; Hullsiek KH; Boulware DR; Meya DB;
Clin Infect Dis; 2019 May; 68(12):2094-2098. PubMed ID: 30256903
[TBL] [Abstract][Full Text] [Related]
7. Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
Jarvis JN; Bicanic T; Loyse A; Namarika D; Jackson A; Nussbaum JC; Longley N; Muzoora C; Phulusa J; Taseera K; Kanyembe C; Wilson D; Hosseinipour MC; Brouwer AE; Limmathurotsakul D; White N; van der Horst C; Wood R; Meintjes G; Bradley J; Jaffar S; Harrison T
Clin Infect Dis; 2014 Mar; 58(5):736-45. PubMed ID: 24319084
[TBL] [Abstract][Full Text] [Related]
8. Presence of Epstein-Barr virus in cerebrospinal fluid is associated with increased mortality in HIV-negative cryptococcal meningitis.
Lu Y; Li S; Su Z; Luo C; Gu M; Yuan D; Qin BE; Dai K; Xia H; Chen Y; Peng F; Jiang Y
Med Mycol; 2024 May; 62(5):. PubMed ID: 38710585
[TBL] [Abstract][Full Text] [Related]
9. Unique clinical features of cryptococcal meningitis among Chinese patients without predisposing diseases against patients with predisposing diseases.
Xu L; Zhang X; Guo Y; Tao R; Dai X; Yang Z; Huang Y; Zhu B; Xu Y
Med Mycol; 2019 Nov; 57(8):944-953. PubMed ID: 30657946
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics, treatment, and outcome of low-risk non-HIV-associated cryptococcal meningitis: A retrospective cohort study.
Liu J; Dong R; Zhang H; Yao S; Liu J; Yang L; Fan L; Su X; Wang A; Su Z; Ngai IK; Dai K; Jiang Y; Peng F
Med Mycol; 2023 Dec; 61(12):. PubMed ID: 38031335
[TBL] [Abstract][Full Text] [Related]
11. The utility of cerebrospinal fluid white cell count during the prognostic assessment for cryptococcal meningitis patients: a retrospective study.
Qu J; Jiang J; Lv X
BMC Infect Dis; 2020 Aug; 20(1):571. PubMed ID: 32758162
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of trypan blue stain in a haemocytometer for rapid detection of cerebrospinal fluid sterility in HIV patients with cryptococcal meningitis.
Kwizera R; Akampurira A; Kandole TK; Nielsen K; Kambugu A; Meya DB; Boulware DR; Rhein J;
BMC Microbiol; 2017 Aug; 17(1):182. PubMed ID: 28830348
[TBL] [Abstract][Full Text] [Related]
13. Point-of-care diagnosis and prognostication of cryptococcal meningitis with the cryptococcal antigen lateral flow assay on cerebrospinal fluid.
Kabanda T; Siedner MJ; Klausner JD; Muzoora C; Boulware DR
Clin Infect Dis; 2014 Jan; 58(1):113-6. PubMed ID: 24065327
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.
Williams DA; Kiiza T; Kwizera R; Kiggundu R; Velamakanni S; Meya DB; Rhein J; Boulware DR
Clin Infect Dis; 2015 Aug; 61(3):464-7. PubMed ID: 25838287
[TBL] [Abstract][Full Text] [Related]
15. The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.
Rolfes MA; Hullsiek KH; Rhein J; Nabeta HW; Taseera K; Schutz C; Musubire A; Rajasingham R; Williams DA; Thienemann F; Muzoora C; Meintjes G; Meya DB; Boulware DR
Clin Infect Dis; 2014 Dec; 59(11):1607-14. PubMed ID: 25057102
[TBL] [Abstract][Full Text] [Related]
16. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi.
Maher D; Mwandumba H
J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Clinical Features and Prognostic Factors of Cryptococcal Meningitis Caused by Cryptococcus neoformans in Patients With and Without Pulmonary Nodules.
Cao W; Jian C; Zhang H; Xu S
Mycopathologia; 2019 Feb; 184(1):73-80. PubMed ID: 29737452
[TBL] [Abstract][Full Text] [Related]
18. Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective Cohort.
Tugume L; Fieberg A; Ssebambulidde K; Nuwagira E; Williams DA; Mpoza E; Rutakingirwa MK; Kagimu E; Kasibante J; Nsangi L; Jjunju S; Musubire AK; Muzoora C; Lawrence DS; Rhein J; Meya DB; Hullsiek KH; Boulware DR; Abassi M;
Open Forum Infect Dis; 2022 Jul; 9(7):ofac301. PubMed ID: 35891691
[TBL] [Abstract][Full Text] [Related]
19. Comparisons of clinical features and mortality of cryptococcal meningitis between patients with and without human immunodeficiency virus infection.
Lee YC; Wang JT; Sun HY; Chen YC
J Microbiol Immunol Infect; 2011 Oct; 44(5):338-45. PubMed ID: 21524972
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Biofire FilmArray meningitis/encephalitis assay for the detection of Cryptococcus neoformans/gattii.
Van TT; Kim TH; Butler-Wu SM
Clin Microbiol Infect; 2020 Oct; 26(10):1375-1379. PubMed ID: 31972318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
